CD8A and neoplasm: These results suggested that, while Neo2/15 is capable of augmenting a polyclonal endogenous response to B16 tumours, in DC15-M9 vaccinated mice the vaccine-elicited CD8 T cells may also contribute to tumour control (figure 6).